NFL BIOSCIENCES

NFL BIOSCIENCES is a biotechnology and pharmaceutical startup founded in 2009. The company's slogan, "Two Simple Injections for Total Smoking Cessation," encapsulates its core mission. Through the clinical development of NFL-101, a patented botanical drug candidate, the company aims to increase smoking cessation rates among individuals looking to quit. NFL-101 is administered via two subcutaneous injections, one week apart, enhancing patient compliance. The product has garnered substantial anecdotal evidence from over 10,000 smokers treated in France with a predecessor product, indicating its safety and effectiveness for total smoking cessation at twelve months. A Phase 1 clinical trial conducted in 2017 further reaffirmed the safety and efficacy of NFL-101 for smokers attempting to quit, both in terms of total cessation and reduction without compensatory over-smoking. Although details of last investment and investors are not available, NFL BIOSCIENCES' innovative approach to smoking cessation presents an intriguing opportunity in the biotech and pharmaceutical industries.